These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9312760)
1. [The effect of human recombinant erythropoietin on distribution of membrane phospholipids in blood platelets of patients with uremia treated with repeated hemodialysis]. Krawczyk W; Ledwozyw A; Dmoszyńska A; Krzywicka A; Rózyc P Pol Arch Med Wewn; 1997 Feb; 97(2):120-5. PubMed ID: 9312760 [TBL] [Abstract][Full Text] [Related]
2. [The effect of human recombinant erythropoietin on levels of plasma phospholipids in patients chronically treated with hemodialysis]. Krawczyk W; Dmoszyńska A; Ledwozyw A; Marczewski K Pol Arch Med Wewn; 1995 Jul; 94(1):21-5. PubMed ID: 8524695 [TBL] [Abstract][Full Text] [Related]
3. Human erythropoietin improves the blood platelet phospholipid composition in chronically hemodialyzed patients. Krawczyk W; Dmoszyńska A; Marczewski K; Ledwozyw A Exp Nephrol; 1995; 3(4):265-6. PubMed ID: 8590040 [TBL] [Abstract][Full Text] [Related]
4. [Effect of human recombinant erythropoietin (rhuEPO) on platelet phospholipids in chronically hemodialysed]. Krawczyk W; Dmoszyńska A; Ledwozyw A; Soroka-Wojtaszko M Acta Haematol Pol; 1993; 24(4):327-31. PubMed ID: 8303978 [TBL] [Abstract][Full Text] [Related]
5. [The composition of fatty acids in individual classes of blood platelet phospholipids of patients with uremia]. Krawczyk W; Dmoszyńska A; Ledwozyw A Pol Arch Med Wewn; 1993 May; 89(5):377-84. PubMed ID: 8367371 [TBL] [Abstract][Full Text] [Related]
6. [Distribution of phospholipids in platelet membranes and platelet factor 3 availability in patients with chronic kidney failure]. Krawczyk W; Dmoszyńska A; Ledwozyw A Pol Arch Med Wewn; 1993 Dec; 90(6):409-15. PubMed ID: 8146043 [TBL] [Abstract][Full Text] [Related]
7. [Distribution of platelet membrane phospholipids in patients chronically hemodialyzed using cuprophane and cellulose acetate membranes]. Krawczyk W; Marczewski K; Ledwozyw A; Dmoszyńska A Pol Arch Med Wewn; 1994 Jul; 92(1):41-6. PubMed ID: 7971476 [TBL] [Abstract][Full Text] [Related]
8. The effect of erythropoietin on platelet function in uraemic children on haemodialysis. Turi S; Soos J; Torday C; Bereczki C; Havass Z Pediatr Nephrol; 1994 Dec; 8(6):727-32. PubMed ID: 7696114 [TBL] [Abstract][Full Text] [Related]
9. [The influence of recombinant human erythropoietin on platelet phospholipid fatty acid composition in patients on long term hemodialysis]. Krawczyk W; Dmoszyńska A; Ledwozyw A Pol Merkur Lekarski; 1996 Dec; 1(6):394-7. PubMed ID: 9273229 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and uremic platelet aggregation in vivo and in vitro. Malyszko JS; Malyszko J; Pawlak K; Mysliwiec M Int J Clin Lab Res; 1996; 26(3):199-202. PubMed ID: 8905452 [TBL] [Abstract][Full Text] [Related]
11. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling. Díaz-Ricart M; Estebanell E; Cases A; Calls J; López-Pedret J; Carretero M; Castillo R; Ordinas A; Escolar G Kidney Int; 2000 May; 57(5):1905-14. PubMed ID: 10792609 [TBL] [Abstract][Full Text] [Related]
12. Enhanced platelet apoptosis in chronic uremic patients. Li M; Wang Z; Ma T; Lu G; Yan R; Zhao L; Deng K; Dai K Ren Fail; 2014 Jul; 36(6):847-53. PubMed ID: 24655051 [TBL] [Abstract][Full Text] [Related]
13. [Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients]. Cases A; Escolar G; Reverter JC; Garrido M; Ordinas A; López-Pedret J; Castillo R; Revert L Med Clin (Barc); 1990 Nov; 95(17):644-7. PubMed ID: 2089202 [TBL] [Abstract][Full Text] [Related]
14. Effects of erythropoietin and aminoguanidine on red blood cell deformability in diabetic azotemic and uremic patients. Brown CD; Zhao ZH; Thomas LL; deGroof R; Friedman EA Am J Kidney Dis; 2001 Dec; 38(6):1414-20. PubMed ID: 11728984 [TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function. Tàssies D; Reverter JC; Cases A; Calls J; Escolar G; Ordinas A Am J Hematol; 1998 Oct; 59(2):105-9. PubMed ID: 9766793 [TBL] [Abstract][Full Text] [Related]
16. Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients. Pawlak K; Pawlak D; Mysliwiec M Am J Nephrol; 2006; 26(5):497-502. PubMed ID: 17119331 [TBL] [Abstract][Full Text] [Related]
17. The acute effect of intravenously administered recombinant human erythropoietin on the immune response of uremic patients maintained on regular hemodialysis. William J; Saad N; Salib M; Riad H; Mahran KS; Iskander I; Cozma G; Barsoum R Artif Organs; 1998 Mar; 22(3):192-6. PubMed ID: 9527278 [TBL] [Abstract][Full Text] [Related]
18. Reduced production, absorption, and elimination of erythropoietin in uremia compared with healthy volunteers. Jensen JD; Madsen JK; Jensen LW; Pedersen EB J Am Soc Nephrol; 1994 Aug; 5(2):177-85. PubMed ID: 7993997 [TBL] [Abstract][Full Text] [Related]
19. The effect of recombinant human erythropoietin (r-Hu EPO) administration on the blood chemistries and composition in uremic rats. Kozioł M; Ksiazek P; Feldo M; Spasiewicz D; Michalak J; Kleinrok Z Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():61-6. PubMed ID: 8192533 [TBL] [Abstract][Full Text] [Related]
20. Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia. Bonomini M; Dottori S; Amoroso L; Arduini A; Sirolli V J Thromb Haemost; 2004 Aug; 2(8):1275-81. PubMed ID: 15304031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]